A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer

Since the prognosis of advanced biliary tract cancer (aBTC) still remains very poor, new therapeutic approaches, including immunotherapies, need to be developed. In the current study, we conducted an open‐label randomized phase II study to test whether low dose cyclophosphamide (CPA) could improve a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Shirahama, Takahisa, Muroya, Daisuke, Matsueda, Satoko, Yamada, Akira, Shichijo, Shigeki, Naito, Masayasu, Yamashita, Takuto, Sakamoto, Shinjiro, Okuda, Koji, Itoh, Kyogo, Sasada, Tetsuro, Yutani, Shigeru
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5448649/
https://ncbi.nlm.nih.gov/pubmed/28188670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13193
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados